Primary Care Clinics in Grasonville, MD Accepting Medicare
3 Primary Care Clinics found. Showing 1 - 3
 Joel H. Wilkerson Md And Associates Llc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 204 Medical Center Rd., Grasonville, MD 21638 Phone: 410-827-7117 Fax: 410-827-9030 |
Grasonville Head Start Dental Services Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Not Enrolled in Medicare Practice Location: 5441 Main St, Grasonville, MD 21638 Phone: 410-479-5772 Fax: 410-479-8397 |
Preventive Care Network Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 204 Medical Center Dr, Grasonville, MD 21638 Phone: 410-827-8117 |
News Archive
Subclinical inflammation predicts macular disease
Levels of high-sensitivity C-reactive protein predict the risk for age-related macular degeneration and diabetic macular edema, show results of two independent studies published in JAMA Ophthalmology.
Administration considers extending COBRA premiums
The Obama administration announced Monday that it is considering extending a federal law that subsidizes COBRA health insurance premiums for laid-off workers.
TQ can suppress growth of aggressive PCa cell lines: Researchers
Researchers at the Tulane University School of Medicine, in New Orleans, LA, have demonstrated that thymoquinone a major component of black seed oil (Nigella sativa) can suppress the growth of several aggressive prostate cancer cell lines, in vitro. Although previous studies have shown the anti-proliferative effects of TQ in different types of cancers, the molecular mechanism of this effect of TQ had not been delineated.
Medicines for All Institute partners with South African manufacturer to increase access to lifesaving drugs
The Medicines for All Institute has entered into a partnership with a manufacturer in South Africa to commercialize advances made by the institute to improve access to lifesaving medications for HIV/AIDS and other diseases.
FDA approves Atacand (candesartan cilexetil) for the treatment of heart failure
AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved its angiotensin receptor blocker (ARB) Atacand (candesartan cilexetil) Tablets for the treatment of heart failure (NYHA class II-IV and ejection fraction less than or equal to 40%) to reduce the risk of death from cardiovascular causes and reduce hospitalizations for heart failure.
› Verified 4 days ago